MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income (loss)
$391,000K
Proceeds from issuance of
common stock, net of...
$49,883K
Stock-based compensation
$52,135K
Amortization of intangible
assets
$10,889K
Operating lease
right-of-use assets
-$8,667K
Long-term liabilities
$1,081K
Depreciation
$871K
Net cash provided by
operating activities
$109,836K
Net cash provided by
financing activities
$49,883K
Effect of exchange rate
changes on cash
$26K
Canceled cashflow
$354,807K
Net (decrease)
increase in cash, cash...
-$142,819K
Canceled cashflow
$159,745K
Sale and maturity of
investment securities
$493,529K
Deferred income taxes
(including benefit from...
-$249,879K
Accounts receivable, net
$22,718K
Interest and other
receivables
$20,818K
Accrued liabilities
-$19,265K
Inventory
$18,197K
Operating lease
liabilities
-$6,516K
Amortization of premiums and
accretion of discounts on...
$5,424K
Accounts payable
-$5,289K
Prepaid expenses and
other current assets
$3,845K
Other assets
$2,856K
Net cash (used in)
provided by investing...
-$302,564K
Canceled cashflow
$493,529K
Purchases of investment
securities
$692,565K
Payment of milestone and
contingent payments in...
$98,838K
Net purchases of
property and equipment
$4,690K
Back
Back
Cash Flow
source: myfinsight.com
ACADIA PHARMACEUTICALS INC (ACAD)
ACADIA PHARMACEUTICALS INC (ACAD)